PA8451801A1 - Derivados de la 9-oxima eritromicina - Google Patents

Derivados de la 9-oxima eritromicina

Info

Publication number
PA8451801A1
PA8451801A1 PA19988451801A PA8451801A PA8451801A1 PA 8451801 A1 PA8451801 A1 PA 8451801A1 PA 19988451801 A PA19988451801 A PA 19988451801A PA 8451801 A PA8451801 A PA 8451801A PA 8451801 A1 PA8451801 A1 PA 8451801A1
Authority
PA
Panama
Prior art keywords
formula
oxyme
erythromycin
derivatives
compounds
Prior art date
Application number
PA19988451801A
Other languages
English (en)
Spanish (es)
Inventor
Yong-Jin Wu
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PA8451801A1 publication Critical patent/PA8451801A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
PA19988451801A 1997-06-11 1998-05-21 Derivados de la 9-oxima eritromicina PA8451801A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4934997P 1997-06-11 1997-06-11

Publications (1)

Publication Number Publication Date
PA8451801A1 true PA8451801A1 (es) 2000-05-24

Family

ID=21959341

Family Applications (1)

Application Number Title Priority Date Filing Date
PA19988451801A PA8451801A1 (es) 1997-06-11 1998-05-21 Derivados de la 9-oxima eritromicina

Country Status (31)

Country Link
EP (1) EP0988308A1 (cs)
JP (1) JP2000513026A (cs)
KR (1) KR20010013660A (cs)
CN (1) CN1259135A (cs)
AP (1) AP9801253A0 (cs)
AR (1) AR012244A1 (cs)
AU (1) AU7226798A (cs)
BG (1) BG103947A (cs)
BR (1) BR9810021A (cs)
CA (1) CA2293335A1 (cs)
CO (1) CO4940506A1 (cs)
CZ (1) CZ9904388A3 (cs)
EA (1) EA199901016A1 (cs)
GT (1) GT199800074A (cs)
HN (1) HN1998000073A (cs)
HR (1) HRP980316A2 (cs)
HU (1) HUP0002252A3 (cs)
ID (1) ID24529A (cs)
IL (1) IL132767A0 (cs)
IS (1) IS5251A (cs)
MA (1) MA26505A1 (cs)
NO (1) NO996108L (cs)
OA (1) OA11225A (cs)
PA (1) PA8451801A1 (cs)
PE (1) PE79899A1 (cs)
PL (1) PL337606A1 (cs)
TN (1) TNSN98083A1 (cs)
TR (1) TR199902995T2 (cs)
TW (1) TW448174B (cs)
WO (1) WO1998056800A1 (cs)
ZA (1) ZA985018B (cs)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000159A (es) * 1997-10-29 1999-02-09 Monsanto Co Derivados de 9- amino - 3 ceto eritromicina
DE69926005T2 (de) * 1998-09-22 2006-05-18 Pfizer Products Inc., Groton Carbamat- und carbazatketolidantibiotika
FR2786188B1 (fr) * 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments
US6258785B1 (en) 1998-12-02 2001-07-10 Pfizer Inc. Crystalline 9-E-(O-methyl)oxime of 11, 12-dideoxy-3-de(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribohexopyranosyloxy)-6-O-methyl-12,11-(iminocarbonyl-(2-(3-(4-(3-pyridinyl)1H-imadazol-1-yl)propyl)hydrazono))-3-oxoerythromycin
EP1298138B1 (en) * 1998-12-10 2006-11-02 Pfizer Products Inc. Carbamate and Carbazate Ketolide Antibiotics
US6284732B1 (en) * 1998-12-18 2001-09-04 Bio-Rad Laboratories, Inc. Peptides and peptide analogues designed from HFE protein and their uses in the treatment of iron overload diseases
KR20020007374A (ko) * 1999-04-16 2002-01-26 추후제출 매크롤라이드 항감염제
AP2001002302A0 (en) 1999-05-24 2001-10-25 Pfizer Prod Inc 13-Methyl erythromycin derivatives.
CA2378671C (en) * 1999-06-07 2007-04-24 Abbott Laboratories 6-o-carbamate ketolide derivatives
ID27331A (id) * 1999-09-29 2001-03-29 Pfizer Prod Inc Pembuatan antibiotik-antibiotik ketolida karbamat
EP1114826A3 (en) * 1999-12-29 2001-10-31 Pfizer Products Inc. Novel antibacterial and prokinetic macrolides
EP1439186A3 (en) * 1999-12-29 2004-11-03 Pfizer Products Inc. Intermediates for novel antibacterial and prokinetic macrolides
US6946446B2 (en) 2000-02-24 2005-09-20 Abbott Laboratories Anti-infective agents useful against multidrug-resistant strains of bacteria
US6403776B1 (en) 2000-07-05 2002-06-11 Pfizer Inc. Synthesis of carbamate ketolide antibiotics
WO2003090761A1 (en) * 2002-04-25 2003-11-06 Abbott Laboratories 9-oxime macrolide antibacterials
AR043050A1 (es) 2002-09-26 2005-07-13 Rib X Pharmaceuticals Inc Compuestos heterociclicos bifuncionales y metodos para preparar y usar los mismos
EP1638549A4 (en) * 2003-03-10 2011-06-15 Optimer Pharmaceuticals Inc NEW ANTIBACTERIAL AGENTS
EP2716647A3 (en) 2004-02-27 2014-08-20 Rib-X Pharmaceuticals, Inc. Macrocyclic compounds and methods of making and using the same
EP2214484A4 (en) 2007-10-25 2013-01-02 Cempra Pharmaceuticals Inc PROCESS FOR PREPARING ANTIBACTERIAL MAKROLIDE AGENTS
ES2677007T3 (es) 2008-10-24 2018-07-27 Cempra Pharmaceuticals, Inc. Procedimientos para tratar enfermedades resistentes usando macrólidos que contienen triazol
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
CN102724874B (zh) 2009-09-10 2018-06-01 森普拉制药公司 治疗疟疾、结核病和mac疾病的方法
CN102146085B (zh) * 2010-02-09 2014-03-26 北京理工大学 一种9-肟醚酮内酯衍生物、制备方法及其药物组合物
KR102006200B1 (ko) 2010-03-22 2019-08-01 셈프라 파마슈티컬스, 인크. 매크로라이드의 결정 형태들 및 그 용도들
AU2011255464C1 (en) 2010-05-20 2017-02-23 Cempra Pharmaceuticals, Inc. Processes for preparing macrolides and ketolides and intermediates therefor
US9815863B2 (en) 2010-09-10 2017-11-14 Cempra Pharmaceuticals, Inc. Hydrogen bond forming fluoro ketolides for treating diseases
NZ700182A (en) 2012-03-27 2017-02-24 Cempra Pharmaceuticals Inc Parenteral formulations for administering macrolide antibiotics
EP2968801B1 (en) 2013-03-14 2018-09-26 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
RU2015138797A (ru) 2013-03-15 2017-04-24 Семпра Фармасьютикалс, Инк. Конвергентные способы получения макролидных антибактериальных агентов

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of erythromycin derivatives
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Also Published As

Publication number Publication date
CZ9904388A3 (cs) 2002-10-16
EA199901016A1 (ru) 2000-06-26
BR9810021A (pt) 2000-09-19
HRP980316A2 (en) 1999-04-30
NO996108D0 (no) 1999-12-10
HUP0002252A2 (hu) 2000-12-28
CA2293335A1 (en) 1998-12-17
TW448174B (en) 2001-08-01
AP9801253A0 (en) 1999-12-04
ZA985018B (en) 1999-12-10
EP0988308A1 (en) 2000-03-29
OA11225A (en) 2003-07-17
NO996108L (no) 2000-02-10
KR20010013660A (ko) 2001-02-26
CO4940506A1 (es) 2000-07-24
HUP0002252A3 (en) 2002-01-28
PE79899A1 (es) 1999-08-25
CN1259135A (zh) 2000-07-05
AR012244A1 (es) 2000-09-27
ID24529A (id) 2000-07-20
AU7226798A (en) 1998-12-30
HN1998000073A (es) 1999-01-08
TR199902995T2 (xx) 2000-02-21
BG103947A (en) 2000-07-31
JP2000513026A (ja) 2000-10-03
WO1998056800A1 (en) 1998-12-17
GT199800074A (es) 1999-11-27
MA26505A1 (fr) 2004-12-20
PL337606A1 (en) 2000-08-28
IL132767A0 (en) 2001-03-19
IS5251A (is) 1999-11-16
TNSN98083A1 (fr) 2005-03-15

Similar Documents

Publication Publication Date Title
PA8451801A1 (es) Derivados de la 9-oxima eritromicina
PA8442001A1 (es) Derivados de pirimidina biciclica condensada
CO4810375A1 (es) Derivados de 9-amino-3-ceto eritromicina
PA8452001A1 (es) Derivados de macrolidos c-4" sustituidos
PA8452201A1 (es) Derivados de 9-desoxo-9a-aza-9a -homoeritromicina a c-4"sustituidos.
ES2161290T3 (es) Derivados de quinazolina.
YU11997A (sh) Laktamski derivati i njihove farmaceutske kompozicije
PA8465901A1 (es) Nuevos derivados de la eritromicina
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
BR0010938A (pt) Derivados da 13-metil eritromicina
DK2314582T3 (da) Heterocykliske forbindelser som antivirusmidler
PA8547701A1 (es) Nucleosidos 4 substituidos.
ECSP024399A (es) Derivados de benzotiazol
GT199800180A (es) Derivados de la tienopirimidina y de la tienopiridina utiles como agentes anticancerigenos.
MX9503529A (es) Derivados de glicinamida, procedimiento para su preparacion y medicamentos que los contienen.
PA8485601A1 (es) Azalidas de 13 miembros y su uso como agentes antibioticos.
ES2182114T3 (es) Derivados azabiciclicos de la carbamoiloxi-multilina para empleo antibacteriano.
TR200000153T2 (tr) İl-5 inhibite eden 6-azaurasil türevleri.
UY28535A1 (es) Derivados de bencimidazol, composiciones que los contienen, preparacion y usos de los mismos.
AR025379A1 (es) 9a-azalidas con actividad antibacteriana.
BR0315106A (pt) Derivados antimicrobianos de [3.1.0]oxazolidinona bicìclica
PA8450901A1 (es) Derivados de eritromicina
ES2192789T3 (es) Derivados de hidrazono-benzazuleno, composiciones farmaceuticas y compuestos intermedios.
PA8474401A1 (es) 3-ceto derivados triciclicos de 6-0-metileritromicina
SV2002000211A (es) Derivados de higromicina ref. pc10726abcz/bb